🛡️ Specialized Clinical Reference Tool • cccr.borefox.com

CCCR Calculator 2026

Calcium Creatinine Clearance Ratio Calculator

Use this clinical calculator to accurately calculate the calcium creatinine clearance ratio (CCCR) from urine and serum calcium and creatinine measurements for differential diagnosis.

1 Laboratory Value Entry
Sample Data:
Enter paired urine and serum laboratory measurements. Compatible units are automatically converted internally.
24-hr aliquot or spot urine
Total blood calcium
Same urine specimen
Concurrent blood draw
ℹ️ Dimensionless ratio calculated using normalized concentrations
Standard Formula: CCCR = (UCa × SCr) ÷ (SCa × UCr)
Equivalent to: (Calcium Clearance) ÷ (Creatinine Clearance)
CLINICAL OVERVIEW

What is the Calcium Creatinine Clearance Ratio (CCCR)?

The Calcium Creatinine Clearance Ratio (CCCR), also known in clinical nephrology and endocrinology as the fractional excretion of calcium (FE-Ca) or the calcium-to-creatinine clearance ratio, is a mathematical tool that evaluates how efficiently the kidneys reabsorb or excrete calcium relative to creatinine filtration.

In normal human physiology, approximately 98% to 99% of calcium filtered by the glomeruli is actively and passively reabsorbed throughout the renal tubules (primarily in the proximal tubule and the thick ascending limb of Henle). In states of systemic hypercalcemia, understanding whether the kidneys are appropriately spilling excess calcium or paradoxically holding onto it is crucial for identifying the underlying etiology.

Because creatinine clearance serves as an endogenous benchmark of glomerular filtration rate (GFR), comparing calcium clearance directly to creatinine clearance eliminates the need for strict volumetric timing (such as measuring the exact milliliter output of a 24-hour jug), making CCCR a highly practical clinical marker.

BIOCHEMICAL MECHANICS

How CCCR is Calculated: The Physiological Formula

By definition, the clearance of any substance x (Cx) is given by:

Clearance (Cx) = (Ux × V) ÷ Sx

Where Ux is the urinary concentration, V is the urine flow rate (volume over time), and Sx is the serum concentration.

When we express the clearance of calcium as a fraction of creatinine clearance:

CCCR = CCa ÷ CCr
CCCR = [ (UCa × V) ÷ SCa ] ÷ [ (UCr × V) ÷ SCr ]
CCCR = (UCa × SCr) ÷ (SCa × UCr)

Notice that urine volume (V) appears in both the numerator and denominator and cancels out entirely. Consequently, CCCR is completely independent of total urine volume, which is why it can be calculated from a spot urine sample as well as an aliquot of a 24-hour collection.

DIFFERENTIAL DIAGNOSIS

CCCR in the Evaluation of Hypercalcemia: FHH vs. PHPT

Familial Hypocalciuric Hypercalcemia (FHH)

FHH is an autosomal dominant condition most commonly caused by heterozygous loss-of-function mutations in the CASR gene (FHH Type 1), or less commonly GNA11 (Type 2) or AP2S1 (Type 3).

Because the calcium-sensing receptor setpoint in both the parathyroid glands and the renal thick ascending limb is shifted upward, the kidneys perceive hypercalcemic blood levels as "normal" and avidly reabsorb calcium.

Typical Laboratory Pattern:
  • Mild, lifelong, asymptomatic hypercalcemia
  • Normal or mildly elevated intact PTH
  • Low fractional calcium excretion (typically CCCR < 0.01)
  • Low 24-hour absolute urinary calcium (< 100 mg/24h or < 2.5 mmol/24h)
  • Crucial clinical note: FHH is benign and does not benefit from parathyroidectomy.

Primary Hyperparathyroidism (PHPT)

PHPT is characterized by autonomous, uninhibited secretion of parathyroid hormone (PTH), usually by a solitary parathyroid adenoma (~85%) or multigland parathyroid hyperplasia.

Although PTH directly stimulates renal tubular calcium reabsorption, the marked systemic hypercalcemia increases the total filtered load of calcium presented to the glomerulus, overwhelming renal reabsorption and resulting in higher calcium excretion.

Typical Laboratory Pattern:
  • Hypercalcemia with elevated or inappropriately normal PTH
  • Normal or elevated fractional excretion (typically CCCR > 0.02)
  • Normal or elevated 24-hour urinary calcium excretion
  • Risk of nephrolithiasis, osteoporosis, and renal impairment
  • Crucial clinical note: Surgical parathyroidectomy is curative in eligible patients.
⚠️ The 0.01 to 0.02 "Grey Zone" and Diagnostic Overlap

International workshop guidelines (e.g., Bilezikian et al., 2022) explicitly warn that approximately 15% to 20% of FHH patients exhibit CCCR values between 0.01 and 0.02. Conversely, up to 10% to 22% of surgically proven PHPT patients (particularly those with concomitant vitamin D deficiency or reduced kidney clearance) have a CCCR under 0.02 or even below 0.01.

DIAGNOSTIC ACCURACY

Clinical Confounders & Critical Limitations

Accurate interpretation of the Calcium Creatinine Clearance Ratio requires ruling out physiological, pharmacological, and renal confounders that alter urinary calcium excretion:

1. 25-Hydroxyvitamin D Deficiency

Vitamin D deficiency reduces intestinal calcium absorption and secondary PTH elevations promote maximal renal calcium conservation. This can artificially lower CCCR into the FHH range (< 0.01) in patients who actually have PHPT. Vitamin D repletion (target > 20-30 ng/mL) is mandatory prior to definitive assessment.

2. Thiazide Diuretics

Thiazide diuretics (e.g. hydrochlorothiazide, chlorthalidone) directly enhance proximal and distal calcium reabsorption, producing drug-induced hypocalciuria and suppressing CCCR. Testing should be conducted off thiazides when safely possible.

3. Renal Insufficiency (CKD)

When estimated GFR falls below 60 mL/min/1.73m², tubular handling of both calcium and creatinine becomes unpredictable. CCCR loses diagnostic specificity in moderate to advanced renal disease.

4. Dietary Calcium Restriction

Very low dietary calcium intake decreases total urinary calcium excretion, potentially depressing CCCR values. Patients should maintain their usual non-restricted diet prior to collection.

PATIENT & CLINICIAN FAQS

Frequently Asked Questions about CCCR

A CCCR calculator is a specialized medical tool that computes the Calcium Creatinine Clearance Ratio (also termed the fractional excretion of calcium) from paired serum and urine calcium and creatinine values. It helps clinicians objectively assess renal calcium handling during the diagnostic workup of hypercalcemia.

CCCR stands for Calcium Creatinine Clearance Ratio, which is also widely known in medical endocrinology as the fractional excretion of calcium (FE-Ca).

CCCR is calculated using the formula: (Urine Calcium × Serum Creatinine) ÷ (Serum Calcium × Urine Creatinine). Notice that urine volume cancels out entirely.

You need four paired laboratory values: Serum Calcium, Serum Creatinine, Urine Calcium, and Urine Creatinine, measured from the same collection timeframe.

Yes, mg/dL or mmol/L can be used as long as the units for calcium match between serum and urine, and the units for creatinine match between serum and urine.

A value below 0.01 (1%) is strongly suggestive of Familial Hypocalciuric Hypercalcemia (FHH), indicating high renal conservation of calcium.

No. Due to the 0.01 to 0.02 overlap "grey zone", CCCR is not a standalone definitive diagnostic test. Clinical assessment, vitamin D status, and family history must be considered.

PHPT patients typically present with higher fractional excretion values (often > 0.02), distinguishing them from FHH patients who conserve calcium more avidly.

Yes, because urine volume cancels out mathematically in the equation, a spot random urine sample yields the same ratio result as a timed 24-hour collection.

Mixed units will break the mathematical cancellation ratio, leading to severely skewed clearance values and potential misdiagnosis.

Content Responsibility & Medical Methodology

This specialized calculation tool was constructed exclusively in accordance with validated clinical formulas and peer-reviewed consensus statements published by international endocrinology and bone mineral research societies.

Editorial Standard:

We do not fabricate physician profiles, doctor reviews, or artificial endorsements. Medical information and calculation methodology should be independently verified against the cited clinical references.

Primary Medical References

View All References

Familial hypocalciuric hypercalcaemia I–III: clinical and laboratory findings in patients with CASR, GNA11, and AP2S1 mutations

Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L (2020). European Journal of Endocrinology.

Evaluates large cohorts of genetically verified FHH types 1, 2, and 3. Demonstrates that while CCCR < 0.01 has high specificity for FHH, up to 20–35% of genetically proven FHH patients may exhibit CCCR values in the indeterminate 0.01–0.02 range.

Scroll to Top